Kristyn Simcha Masters | |
---|---|
Alma mater | Rice University University of Michigan, Ann Arbor |
Scientific career | |
Institutions | University of Colorado Boulder University of Colorado Denver University of Wisconsin Madison |
Thesis | Pharmacologically active materials for localized nitric oxide therapy (2002) |
Website | [Masters Lab https://kmasters4.wixsite.com/masters-labcurrent] |
Kristyn Simcha Masters is an American bioengineer who is professor and Chair of the Department of Bioengineering at the University of Colorado Denver. She works as Director of the Anschutz Medical Campus Center. Her research looks to create tissue-engineered models of disease, with a focus on cancer and cardiac disease.
Masters studied chemical engineering at the University of Michigan, Ann Arbor. She moved to Rice University for her doctorate, where she studied pharmacologically active materials for nitric oxide therapy. [1] She moved to the University of Colorado Boulder for postdoctoral research.[ citation needed ]
Masters joined the University of Wisconsin–Madison in 2004, where she developed tissue-engineered models of disease, with a focus on cancer and heart disease. [2] To do this, she studied the interactions between cells and biomaterials, investigating how the cellular microenvironment impacts cell behavior. [3] She was made the Vilas Distinguished Achievement Professor in 2016. [4]
Masters moved to the University of Colorado Denver in 2023, where she was made Chair of the Department of Bioengineering and Director of the Anschutz Medical Campus Center. [5]
Ali Khademhosseini is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering, an Associate Professor of Surgery, and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels, tissue engineering, and regenerative medicine.
A simulated body fluid (SBF) is a solution with an ion concentration close to that of human blood plasma, kept under mild conditions of pH and identical physiological temperature. SBF was first introduced by Kokubo et al. in order to evaluate the changes on a surface of a bioactive glass ceramic. Later, cell culture media, in combination with some methodologies adopted in cell culture, were proposed as an alternative to conventional SBF in assessing the bioactivity of materials.
Edward Wilson Merrill was an American biomaterials scientist. He was one of the founders of bioengineering, and specifically the biomedical engineering field it developed from chemical engineering. Merrill was born to Edward Clifton Merrill (1881–1949), a chemical engineer and chief chemist of the United Drug Company (Rexall) and Gertrude Wilson (1895–1978).
The in vivo bioreactor is a tissue engineering paradigm that uses bioreactor methodology to grow neotissue in vivo that augments or replaces malfunctioning native tissue. Tissue engineering principles are used to construct a confined, artificial bioreactor space in vivo that hosts a tissue scaffold and key biomolecules necessary for neotissue growth. Said space often requires inoculation with pluripotent or specific stem cells to encourage initial growth, and access to a blood source. A blood source allows for recruitment of stem cells from the body alongside nutrient delivery for continual growth. This delivery of cells and nutrients to the bioreactor eventually results in the formation of a neotissue product.
Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.
Treena Livingston Arinzeh is professor of biomedical engineering at Columbia University in New York, New York, joining in 2022. She was formerly a Distinguished Professor in Biomedical Engineering at the New Jersey Institute of Technology in Newark, New Jersey. She is known for her research on adult stem-cell therapy. Arinzeh takes part in the American Chemical Society's Project Seeds program, opening up her lab for high school students from economically disadvantaged backgrounds for summer internships.
Joyce Y. Wong is an American engineer who is Professor of Biomedical Engineering and Materials Science and Engineering at Boston University. Her research develops novel biomaterials for the early detection treatment of disease. Wong is the Inaugural Director of the Provost's Initiative to promote gender equality and inclusion in STEM at all levels: Advance, Recruit, Retain and Organize Women in STEM. She is a Fellow of the American Association for the Advancement of Science, American Institute for Medical and Biological Engineering and Biomedical Engineering Society.
Sarah Harriet Cartmell is a British biomaterials scientist and Professor of Bioengineering at the University of Manchester. She specializes on the potential use of electrical regimes to influence cellular activity for orthopaedic tissue engineering applications.
Thomas J. Webster is an American biomedical engineer, researcher, and entrepreneur. Throughout his over 25-year academic career, his research group has produced several books and book chapters. He has over 1350 publications and has an H-index of 118. This high H-index places him amongst the top 1% of researchers in his field.
Ipsita Roy is a British-Indian materials scientist who is a professor at the University of Sheffield. Her research considers natural polymers of bacterial origin for medical applications. She was elected to the New York Academy of Sciences in 1997 and serves as the Editor of the Journal of Chemical Technology & Biotechnology.
Shelly R. Peyton is an American chemical engineer who is the Armstrong Professional Development Professor in the Department of CHemical Engineering at the University of Massachusetts Amherst. Her research considers the development of biomaterials to investigate metastatic cancer and potential new therapies.
Elizabeth Cosgriff-Hernandez is an American biomedical engineer who is a professor at the University of Texas at Austin. Her work involves the development of polymeric biomaterials for medical devices and tissue regeneration. She also serves on the scientific advisory board of ECM Biosurgery and as a consultant to several companies on biostability evaluation of medical devices. Cosgriff-Hernandez is an associate editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering.
Surita Bhatia is an American chemist who is professor and vice provost of faculty affairs at Stony Brook University. Her work considers the structure of soft materials, including polymeric hydrogels and colloidal glasses. She was elected Fellow of the American Institute of Chemical Engineers, the American Institute for Medical and Biological Engineering and the Society of Rheology in 2020.
Michelle Lynn Oyen is an American materials scientist who is a Professor of Biomedical Engineering at Washington University in St. Louis. Her research considers nano indentation and biomimetic materials.
Sally L. McArthur is an Australian materials scientist who is Professor of Biomedical Engineering at Swinburne University of Technology and Research Scientist at CSIRO. Her research considers the development of novel biomaterials for biomedical, nutritional and environmental applications. She was elected Fellow of the Australian Academy of Technology and Engineering in 2021.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
Emilia Entcheva is a Bulgarian–American engineer who is a professor of biomedical engineering at George Washington University. She serves as Director of the Cardiac Optogenetics and Optical Imaging Laboratory. She is a Fellow of the American Institute for Medical and Biological Engineering.
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California, San Diego. Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.
Miqin Zhang is an American materials scientist who is the Kyocera Professor of Materials Science at the University of Washington. Her research considers the development of new biomaterials for medical applications. Her group develops nanoparticles for cancer diagnosis and imaging, biocompatible materials for drug delivery and cell-based biosensors.